Rhenman & Partners Asset Management AB - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 153 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$4,723,000
-26.8%
241,964
-0.1%
0.54%
-16.5%
Q3 2018$6,453,000
-51.5%
242,302
-31.2%
0.65%
-52.5%
Q2 2018$13,306,000
+50.8%
352,302
+30.4%
1.36%
+25.2%
Q1 2018$8,826,000
-14.1%
270,248
+28.0%
1.09%
-21.7%
Q4 2017$10,279,000
-36.0%
211,153
-29.0%
1.39%
-32.3%
Q3 2017$16,069,000
+158.2%
297,400
+168.4%
2.05%
+129.4%
Q2 2017$6,224,000
+31.5%
110,805
-8.3%
0.89%
+19.2%
Q1 2017$4,734,000
+74.6%
120,8050.0%0.75%
+44.2%
Q4 2016$2,711,000
-99.9%
120,8050.0%0.52%
+19.3%
Q3 2016$2,743,482,000
+110613.6%
120,805
+15.1%
0.44%
-0.9%
Q2 2016$2,478,000
+15.7%
105,0000.0%0.44%
+3.5%
Q1 2016$2,142,000
-32.9%
105,000
+69.4%
0.42%
-11.8%
Q4 2015$3,190,000
+5.4%
62,000
-12.7%
0.48%0.0%
Q3 2015$3,026,000
-12.6%
71,000
-6.6%
0.48%
+15.9%
Q2 2015$3,462,00076,0000.42%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 228,873$7,475,0004.17%
PFM Health Sciences, LP 5,326,671$173,969,0003.54%
Marcus Capital, LLC 22,950$750,0002.76%
Partner Investment Management, L.P. 72,284$2,361,0002.55%
CADIAN CAPITAL MANAGEMENT, LP 1,240,944$40,529,0002.19%
HARVEY CAPITAL MANAGEMENT INC 158,580$5,179,0001.94%
SECTORAL ASSET MANAGEMENT INC 498,412$16,278,0001.78%
Everett Capital Advisors UK LLP 551,173$18,001,0001.52%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 125,210$4,089,0001.46%
Atika Capital Management LLC 113,000$3,691,0001.26%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders